Renaissance Technologies (RenTech)'s SLDB Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 124,272 shares of Solid Biosciences Inc. (SLDB) worth $894,758, representing 0.00% of the portfolio. First purchased in 2019-Q1, this long-term strategic position has been held for 29 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in SLDB, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 463,700 shares. Largest reduction occurred in Q4 2025, reducing 410,900 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Solid Biosciences (SLDB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Solid Biosciences (SLDB) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +71,472 | Add 135.36% | 124,272 | $7.20 |
| Q4 2025 | -410,900 | Reduce 88.61% | 52,800 | $5.64 |
| Q3 2025 | +463,700 | New Buy | 463,700 | $6.17 |
| Q2 2025 | -175,400 | Sold Out | 0 | $0.00 |
| Q1 2025 | +92,907 | Add 112.62% | 175,400 | $3.70 |
| Q4 2024 | +9,281 | Add 12.68% | 82,493 | $4.00 |
| Q3 2024 | -204,352 | Reduce 73.62% | 73,212 | $6.97 |
| Q2 2024 | +208,793 | Add 303.61% | 277,564 | $5.67 |
| Q1 2024 | +30,700 | Add 80.64% | 68,771 | $13.32 |
| Q4 2023 | +9,501 | Add 33.26% | 38,071 | $6.15 |
| Q3 2023 | +900 | Add 3.25% | 28,570 | $2.52 |
| Q2 2023 | -11,093 | Reduce 28.62% | 27,670 | $0.01 |
| Q1 2023 | -13,000 | Reduce 25.11% | 38,763 | $0.00 |
| Q4 2022 | -15,722 | Reduce 23.30% | 51,763 | $0.01 |
| Q3 2022 | -27,110 | Reduce 28.66% | 67,485 | $6.99 |
| Q2 2022 | +10,023 | Add 11.85% | 94,595 | $9.23 |
| Q1 2022 | +44,050 | Add 108.71% | 84,572 | $18.00 |
| Q4 2021 | +13,732 | Add 51.26% | 40,522 | $26.26 |
| Q3 2021 | +1,138 | Add 4.44% | 26,790 | $35.83 |
| Q2 2021 | +25,652 | New Buy | 25,652 | $54.89 |
| Q1 2021 | -4,950 | Sold Out | 0 | $0.00 |
| Q4 2020 | -1,560 | Reduce 23.96% | 4,950 | $113.74 |
| Q3 2020 | -2,190 | Reduce 25.17% | 6,510 | $30.41 |
| Q2 2020 | +2,930 | Add 50.78% | 8,700 | $43.91 |
| Q1 2020 | +1,901 | Add 49.13% | 5,770 | $35.88 |
| Q4 2019 | +1,716 | Add 79.70% | 3,869 | $66.68 |
| Q3 2019 | -7,867 | Reduce 78.51% | 2,153 | $155.13 |
| Q2 2019 | +3,593 | Add 55.90% | 10,020 | $86.23 |
| Q1 2019 | +6,427 | New Buy | 6,427 | $138.01 |
Renaissance Technologies (RenTech)'s Solid Biosciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Solid Biosciences Inc. (SLDB) in Q1 2019, acquiring 6,427 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Solid Biosciences Inc. (SLDB) for 29 quarters since Q1 2019.
Renaissance Technologies (RenTech)'s largest addition to Solid Biosciences Inc. (SLDB) was in Q3 2025, adding 463,700 shares worth $2.86 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 124,272 shares of Solid Biosciences Inc. (SLDB), valued at approximately $894,758.
As of the Q1 2026 filing, Solid Biosciences Inc. (SLDB) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Solid Biosciences Inc. (SLDB) was 463,700 shares, as reported at the end of Q3 2025.